The D.C. metro area isn’t really known for its consumer electronics startups. D.C. is no Silicon Valley or Boston.
But that isn’t stopping Maryland-based startup RightEye from using the international 2018 Consumer Electronics Show, or CES, as its stage to debut the next-generation of its eye-tracking health tech product.
Founded in 2012, the Bethesda-based startup creates a vision test that uses its in-house eye-tracking technology to understand a person’s health and wellness. RightEye’s test can screen for concussions, reading issues, Parkinson’s disease, autism and more.
At a CES kickoff event on Jan. 7, the startup unveiled the next generation of this test, called EyeQ. The new tests compare a patients’ vision to the more than 14,000 profiles of patients already tested to produce EyeQ reports for physicians. Each report streamlines the test’s output to prioritize the most important data for the condition being assessed.
Along with updating their tech, RightEye updated their hardware to a portable, rugged PC computer with embedded eye-tracking technology (as pictured above). Sweden-based, eye-tracking tech company Tobii worked with RightEye to develop the hardware. RightEye is exhibiting the tech at CES through Friday.
“The potential for this technology to change people’s lives around the world is incredible and really exciting,” said Adam Gross, RightEye CEO and co-founder, in a press release.
RightEye was founded by Gross and Melissa Hunfalvay six years ago. The duo met through a mutual friend who suggested they meet up and play tennis together. That might seem random, but Hunfalvay is a former professional tennis player, after all. In 2016, Hunfalvay gave a TEDx Talk in Foggy Bottom about the effects of eye-tracking tests.